196 related articles for article (PubMed ID: 31436232)
1. Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma.
Yuan C; Yuan Z; Cui X; Gao W; Zhao P; He N; Cui S; Wang Y; Zhang Y; Li W; Zheng J
J Cancer Res Ther; 2019; 15(4):784-792. PubMed ID: 31436232
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
[TBL] [Abstract][Full Text] [Related]
3. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
Lee LH; Hwang JI; Cheng YC; Wu CY; Lee SW; Yang SS; Yeh HZ; Chang CS; Lee TY
PLoS One; 2017; 12(1):e0169655. PubMed ID: 28068369
[TBL] [Abstract][Full Text] [Related]
4. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
5. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effectiveness and safety of ultrasound- and CT-guided percutaneous radiofrequency ablation of non-operation hepatocellular carcinoma.
Wu J; Chen P; Xie YG; Gong NM; Sun LL; Sun CF
Pathol Oncol Res; 2015 Jul; 21(3):637-42. PubMed ID: 25466642
[TBL] [Abstract][Full Text] [Related]
7. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
[TBL] [Abstract][Full Text] [Related]
9. Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma.
Wu CH; Liang PC; Su TH; Lin MC; Chang YH; Shih TT; Kao JH
Hepatol Int; 2021 Oct; 15(5):1247-1257. PubMed ID: 34338971
[TBL] [Abstract][Full Text] [Related]
10. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
[TBL] [Abstract][Full Text] [Related]
13. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?
Li Z; Wang C; Si G; Zhou X; Li Y; Li J; Jiao D; Han X
BMC Cancer; 2021 Apr; 21(1):366. PubMed ID: 33827464
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
Lee Y; Yoon JH; Han S; Joo I; Lee JM
Cancer Imaging; 2024 Jan; 24(1):4. PubMed ID: 38172949
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
16. Computed tomographic-guided radiofrequency ablation of recurrent or residual hepatocellular carcinomas around retained iodized oil after transarterial chemoembolization.
Koh YH; Choi JI; Kim HB; Kim MJ
Korean J Radiol; 2013; 14(5):733-42. PubMed ID: 24043966
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
[TBL] [Abstract][Full Text] [Related]
18. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility.
Kim PN; Choi D; Rhim H; Rha SE; Hong HP; Lee J; Choi JI; Kim JW; Seo JW; Lee EJ; Lim HK
J Vasc Interv Radiol; 2012 May; 23(5):627-34. PubMed ID: 22387030
[TBL] [Abstract][Full Text] [Related]
19. Utility of Real-time CT/MRI-US Automatic Fusion System Based on Vascular Matching in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: A Prospective Study.
Han S; Lee JM; Lee DH; Yoon JH; Chang W
Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1579-1596. PubMed ID: 34312690
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma.
Huo J; Aloia TA; Xu Y; Chung TH; Sheu T; Tina Shih YC
Value Health; 2019 Mar; 22(3):284-292. PubMed ID: 30832966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
